← FDA Drug Approvals (Drugs@FDA)
DAPSONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2024-08-26
Drug application
- FDA Application #
ANDA213636- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DAPSONE
- Generic name
- DAPSONE
- Active ingredients
- DAPSONE
- Dosage form
- GEL
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- TP ANDA HOLDINGS
- Manufacturer
- Trupharma, LLC
- First approval
- 2024-08-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown